Review: An urgent need for research on factors impacting adherence to and retention in care among HIV-positive youth and adolescents from key populations

Journal of the International AIDS Society

Volumn 18, Issue 2, 2015, Pages 41-53

  Lall, Priya ^a   Lim, Sin How ^a   Khairuddin, Norliana ^a   Kamarulzaman, Adeeba ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Adherence; Antiretroviral therapy; Human immunodeficiency virus; Retention in hiv care; Young key populations

Indexed keywords

ANTIRETROVIRUS AGENT;

AGE; DRUG USE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL CARE; MEDLINE; MEN WHO HAVE SEX WITH MEN; MENTAL HEALTH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRISONER; PROSTITUTION; PSYCINFO; REVIEW; TRANSGENDER; ADOLESCENT; ADULT; CHILD; FEMALE; HIV INFECTIONS; HUMAN; MALE; MEDICAL RESEARCH; MEDICATION COMPLIANCE; TRANSITION TO ADULT CARE; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMEDICAL RESEARCH; CHILD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; TRANSITION TO ADULT CARE; YOUNG ADULT;

EID: 84924079331     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.18.2.19393     Document Type: Review

References (47)

1. Arrive E, Dicko F, Amghar H, Aka AE, Dior H, Bouah B, et al. HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa. PLoS One. 2012;7(3):e33690.
2. Bhattacharya M, Dubey AP, Sharma M. Patterns of diagnosis disclosure and its correlates in HIV-infected North Indian children. J Trop Pediatr. 2011; 57(6):405-11.
3. Kallem S, Renner L, Ghebremichael M, Paintsil E. Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav. 2011;15(6):1121-7.
4. Philbin MM, Tanner AE, DuVal A, Ellen JM, Xu J, Kapogiannis B, et al. Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen Adolescent Medicine Clinics in the United States. AIDS Behav. 2014;18:1501-10.
5. Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, et al. Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults-seven African countries, 2004- 2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1097 - 103.
6. Mellins CA, Tassiopoulos K, Malee K, Moscicki AB, Patton D, Smith R, et al. Behavioural health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behaviour, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS. 2011;25(7):413-22.
7. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65 - 71.
8. Rivers K, Aggleton P. Adolescent sexuality, gender, and the HIV epidemic. BETA. 2001;14:35-40.
9. Naswa S, Marfatia YS. Adolescent HIV/AIDS: issues and challenges. Indian J Sex Transm Dis. 2010;31(1):1-10.
10. Eaton DK, Kann L, Kinchen S, Shanklin S, Flint KH, Hawkins J, et al. Youth risk behaviour surveillance-United States, 2011. MMWR Surveill Summ. 2012;61(4):1-162.
11. Wood EB, Hutchinson MK, Kahwa E, Hewitt H, Waldron N. Jamaican adolescent girls with older male sexual partners. J Nurs Scholarsh. 2011; 43(4):396 - 404.
12. Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIVinfected youth. Top HIV Med. 2009;17(1):14-25.
13. Giannattasio A, Officioso A, Continisio GI, Griso G, Storace C, Coppini S, et al. Psychosocial issues in children and adolescents with HIV infection evaluated with a World Health Organization age-specific descriptor system. J Dev Behav Pediatr. 2011;32(1):52-5.
14. Petersen I, Bhana A, Myeza N, Alicea S, John S, Holst H, et al. Psychosocial challenges and protective influences for socio-emotional coping of HIV+ adolescents in South Africa: a qualitative investigation. AIDS Care. 2010; 22(8):970-8.
15. Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006;118(6):e1745 - 57.
16. Abramowitz S, Koenig LJ, Chandwani S, Orban L, Stein R, Lagrange R, et al. Characterizing social support: global and specific social support experiences of HIV-infected youth. AIDS Patient Care STDS. 2009;23(5):323-30.
17. Kim S, Gerver SM, Fidler S,Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS. 2014; 28(13):1945-56.
18. Tapp C, Milloy M-J, Kerr T, Zhang R, Guillemi S, Hogg RS, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11:86.
19. Belzer ME, Fuchs DN, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999;25(5):316- 9.
20. Martinez J, Bell D, Camacho R, Henry-Reid LM, Bell M, Watson C, et al. Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic. J Natl Med Assoc. 2000;92(2):55.
21. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M, Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13(1):27-40.
22. Rogers AS, Miller S, Murphy DA, Tanney M, Fortune T. The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) program: theory and preliminary results. J Adolesc Health. 2001;29(Suppl 3):30-8.
23. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR, et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157(3):249-55.
24. Flynn PM, Rudy BJ, Douglas SD, Lathey J, Spector SA, Martinez J, et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis. 2004;190(2):271-9.
25. Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR, et al. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2005;159(8):764-70.
26. Puccio JA, Belzer M, Olson J, Martinez M, Salata C, Tucker D, et al. The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study. AIDS Patient Care STDS. 2006;20(6):438-44.
27. Naar-King S, Templin T, Wright K, Frey M, Parsons JT, Lam P. Psychosocial factors and medication adherence in HIV-positive youth. AIDS Patient Care STDS. 2006;20(1):44-7.
28. Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28 - 33.
29. Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J, Adolescent Trials Network for HIV/AIDS Interventions. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care STDS. 2009;23(3):185-94.
30. Garvie PA, Wilkins ML, Young JC. Young, medication adherence in adolescents with behaviourally-acquired HIV: evidence for using a multimethod assessment protocol. J Adolesc Health. 2010;47(5):504-11.
31. Magnus M, Jones K, Phillips G, Binson D, Hightow-Weidman LB, Richards- Clarke C, et al. Characteristics associated with retention among African American and Latino adolescent HIV-positive men: results from the outreach, care, and prevention to engage HIV-seropositive young MSM of color special project of national significance initiative. J Acquir Immune Defic Syndr. 2010; 53(4):529-36.
32. Comulada WS, Swendeman DT, Rotheram-Borus MJ, Mattes KM,Weiss RE. Use of HAART among young people living with HIV. Am J Health Behav. 2003; 27(4):389-400.
33. Agwu AL, Fleishman JA, Korthuis PT, Siberry GK, Ellen JM, Gaur AH, et al. Disparities in antiretroviral treatment: a comparison of behaviourally HIVinfected youth and adults in the HIV Research Network. J Acquir Immune Defic Syndr. 2011;58(1):100-7.
34. Hadland SE, Milloy MJ, Kerr T, Zhang R, Guillemi S, Hogg RS. Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users. AIDS Patient Care STDS. 2012;26:274-80.
35. Wohl AR, Garland WH, Wu J, Au CW, Boger A, Dierst-Davies R, et al. A youth-focused case management intervention to engage and retain young gay men of color in HIV care. AIDS Care. 2011;23(8):988-97.
36. Hightow-Weidman LB, Smith JC, Valera E, Matthews DD, Lyons P. Keeping them in ''STYLE'': finding, linking, and retaining young HIV-positive black and Latino men who have sex with men in care. AIDS Patient Care STDS. 2011;25(1):37-45.
37. Bouris A, Voisin D, Pilloton M, Flatt N, Eavou R, Hampton K, et al. Project nGage: network supported HIV care engagement for younger black men who have sex with men and transgender persons. J AIDS Clin Res. 2013;4:4- 9.
38. Barnes WM, Abramowitz S, Lagrange R, Chandwani S, Moschel DBA, Koenig LJ. Disease-specific knowledge among HIV-infected adolescents: what do they know and how do they learn it? J HIV AIDS Soc Serv. 2013;12(3): 314-32.
39. Gillman J, Davila J, Sansgiry S, Parkinson-Windross D, Miertschin N, Mitts B, et al. The effect of conspiracy beliefs and trust on HIV diagnosis, linkage, and retention in young MSM with HIV. J Health Care Poor Underserved. 2013; 24(1):36 -45.
40. Harper GW, Fernandez IM, Bruce D, Hosek SG, Jacobs RJ, Adolescent Medicine Trials Network for HIV/AIDS Interventions. The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV. AIDS Behav. 2013;17(1):213-23.
41. Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, et al. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav. 2013;18(4):686 -96.
42. Saberi P, Mayer K, Vittinghoff E, Naar-King S, The Adolescent Medicine Trials Network for HIV/AIDS Interventions. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNAand self-reported adherence. AIDS Behav. 2014;4-9. doi: 10.1007/s10461-014- 0806-z
43. Hussen SA, Andes K, Gilliard D, Chakraborty R, Del Rio C, Malebranche DJ. Transition to adulthood and antiretroviral adherence among HIV-positive young black men who have sex with men. Am J Public Health. 2014:e1 - 7.doi: 10.2105/AJPH.2014.301905
44. Gray GE. Adolescent HIV-causes for concern in southern Africa. PLoS Med. 2010;7(2):e1000227.
45. UNAIDS, WHO. 2009 AIDS epidemic update. Geneva: WHO; 2009. p. 7.
46. El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. People who inject drugs in intimate relationships: it takes two to combat HIV. Curr HIV/AIDS Rep. 2014; 11(1):45-1.
47. Tolou-Shams M, Stewart A, Fasciano J, Brown LK. A review of HIV prevention interventions for juvenile offenders. J Pediatr Psychol. 2010; 35(3):250-61.